| Dr Charles J Brook, MD | |
|
6420 Prospect Ave, T303, Kansas City, MO 64132 | |
| (816) 333-1919 | |
| (816) 361-1930 |
| Full Name | Dr Charles J Brook |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 6420 Prospect Ave, Kansas City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841257839 | NPI | - | NPPES |
| 100195760A | Medicaid | KS | |
| 201193208 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | R7565 (Missouri) | Primary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 0418351 (Kansas) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles J Brook, MD 6420 Prospect Ave, T303, Kansas City, MO 64132 Ph: (816) 333-1919 | Dr Charles J Brook, MD 6420 Prospect Ave, T303, Kansas City, MO 64132 Ph: (816) 333-1919 |
News Archive
Interventional treatments-especially surgery-provide good functional outcomes and a high cure rate for patients with lower-grade arteriovenous malformations (AVMs) of the brain, reports the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
Studies of breast cancer risk and treatment outcomes are not taking sufficient account of race/ethnicity, economic status, education level, health insurance status and other social factors, according to scientists at Johns Hopkins Bloomberg School of Public Health.
The U.S. Preventive Services Task Force finds scant evidence that the PSA blood test saves lives and instead says unneeded treatment leads to serious problems, including impotence and incontinence.
Celgene Corporation today announced it has closed its acquisition of Gloucester Pharmaceuticals following the early termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
In recent years, researchers have firmly established that gene mutations appearing for the first time, called de novo mutations, contribute to approximately one-third of cases of autism spectrum disorder.
› Verified 4 days ago
Maria Akram Sheikh, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 Fax: 816-932-3148 | |
Dr. Philip Barigbi Augustine, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4150 N Mulberry Dr, Kansas City, MO 64116 Phone: 816-912-4539 Fax: 855-813-6642 | |
Lucas Vocelka, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd, Bldg 2, Suite 392, Kansas City, MO 64132 Phone: 816-444-7977 Fax: 630-528-9578 | |
Karla L Houston-gray, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr Ste 300, Kansas City, MO 64114 Phone: 816-942-4500 Fax: 816-941-4504 | |
Carl D Dirks, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4320 Wornall Rd, Suite 65, Kansas City, MO 64111 Phone: 816-932-6100 Fax: 816-932-9002 | |
Michelle L Dew, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4330 Wornall Rd, Suite 2000, Kansas City, MO 64111 Phone: 816-931-1883 Fax: 816-756-3645 | |
Brenda J Rogers, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |